TY - JOUR
T1 - Correction to
T2 - Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy (Current Treatment Options in Oncology, (2024), 25, 3, (293-312), 10.1007/s11864-023-01173-1)
AU - Serritella, Anthony Ventu
AU - Hussain, Maha
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.
PY - 2025/2
Y1 - 2025/2
N2 - In Table 1 of this article, the value in row “CHAARTED” under the column “% Synchronous” was mistakenly listed as “Not allowed”; instead, it should be “72.8%”. In table note, the abbreviation “NA not available” should be “NA not applicable”. The original article has been corrected.
AB - In Table 1 of this article, the value in row “CHAARTED” under the column “% Synchronous” was mistakenly listed as “Not allowed”; instead, it should be “72.8%”. In table note, the abbreviation “NA not available” should be “NA not applicable”. The original article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85217565366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217565366&partnerID=8YFLogxK
U2 - 10.1007/s11864-025-01294-9
DO - 10.1007/s11864-025-01294-9
M3 - Comment/debate
C2 - 39862322
AN - SCOPUS:85217565366
SN - 1527-2729
VL - 26
SP - 156
JO - Current treatment options in oncology
JF - Current treatment options in oncology
IS - 2
ER -